Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00041977
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
2002-07-19
Brief Title:
Determine the Effect of Administering PeriostatR Twice Daily on Patients With Acne Rosacea
Sponsor:
CollaGenex Pharmaceuticals
Organization:
CollaGenex Pharmaceuticals
Study Overview
Official Title:
A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial to Determine the Effects of Doxycycline Hyclate 20 Mg Tablets PeriostatR Administered Twice Daily for the Treatment of Acne Rosacea
Status:
COMPLETED
Status Verified Date:
2003-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether PeriostatR Doxycycline Hyclate 20 mg Tablets taken twice daily is effective in reducing the red and white heads and overall redness associated with rosacea
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None